UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sustainable tourism: development, decline and de-growth. Management issues from the Isle of Man

Journal of sustainable tourism, 2014-01, Vol.22 (1), p.127-147

Canavan, B.

2014

Volltextzugriff (PDF)

The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor+ Innate Lymphoid Cells

Immunity (Cambridge, Mass.), 2012-10, Vol.37 (4), p.674-684

2012

Volltextzugriff (PDF)

Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis

Journal of hepatology, 2011-04, Vol.54 (4), p.640-649

2011

Volltextzugriff (PDF)

Improved Insulin Sensitivity despite Increased Visceral Adiposity in Mice Deficient for the Immune Cell Transcription Factor T-bet

Cell metabolism, 2013-04, Vol.17 (4), p.520-533

2013

Volltextzugriff (PDF)

Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls: Implications for Cell Therapy in Transplantation

Clinical journal of the American Society of Nephrology, 2013-08, Vol.8 (8), p.1396-1405

2013

Volltextzugriff (PDF)

Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions

Intestinal research, 2023-07, Vol.21 (3), p.283-294

2023

Volltextzugriff (PDF)

EVALUATION OF OMALIZUMAB IN THE TREATMENT OF ALLERGIC RHINITIS

Chest, 2022-06, Vol.161 (6), p.A8-A8

2022

Volltextzugriff (PDF)

Real world incidence, severity and timing of adverse events (AEs) among patients with metastatic non-small cell lung cancer (NSCLC) receiving second-line (2L) immuno-oncology (IO) therapy vs chemotherapy (C)

Annals of oncology, 2018-10, Vol.29, p.viii436-viii437

2018

Volltextzugriff (PDF)

Flexible Fiberoptic Bronchoscopy Service; An aid to patient management

Irish medical journal, 2016-02, Vol.109 (2), p.360-360

2016

Volltextzugriff (PDF)

Molecular Comparison of Adult and Pediatric Ulcerative Colitis Indicates Broad Similarity of Molecular Pathways in Disease Tissue

Journal of pediatric gastroenterology and nutrition, 2018-07, Vol.67 (1), p.45-52

2018

Volltextzugriff (PDF)

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease

Gut, 2016-04, Vol.65 (4), p.584-594

2016

Volltextzugriff (PDF)

Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2023-08, Vol.165 (2), p.492-495.e2

2023

Volltextzugriff (PDF)

S825 Efficacy of Ozanimod in Vedolizumab-Exposed Patients With Ulcerative Colitis: A Phase 3 True North Post Hoc Analysis

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e593-e594

2022

Volltextzugriff (PDF)

S731 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Baseline Endoscopic Disease Distribution: A Post Hoc Analysis of the Phase 3 True North Study

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e513-e514

2022

Volltextzugriff (PDF)

Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials

Journal of Crohn's and colitis, 2023-08, Vol.17 (8), p.1342-1353

2023

Volltextzugriff (PDF)

Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation

Gastroenterology (New York, N.Y. 1943), 2015-08, Vol.149 (2), p.456-467.e15

2015

Volltextzugriff (PDF)

Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials

Digestive diseases (Basel), 2024, Vol.42 (1), p.12-24

2024

Volltextzugriff (PDF)

S723 Duration of Response to Ozanimod After Treatment Withdrawal: Results From the Phase 3 True North Study

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e506-e507

2022

Volltextzugriff (PDF)

S757 Efficacy and Safety of 2 Years of Continuous Ozanimod Treatment: Interim Analysis of the True North Open-Label Extension Study

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e537-e537

2022

Volltextzugriff (PDF)

S732 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Moderate orSevere Endoscopic Disease Activity at Baseline: A Post Hoc Analysis of the Phase 3 True North Study

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e514-e515

2022

Volltextzugriff (PDF)

CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL‐17 in a STAT3‐dependent manner

European journal of immunology, 2013-08, Vol.43 (8), p.2043-2054

2013

Volltextzugriff (PDF)

Prevalence and Severity of Diverticular Disease in the Post-Lung Transplant Population – A Single Center’s Experience

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S268-S268

2013

Volltextzugriff (PDF)

Statistics 101

Canadian Medical Association journal (CMAJ), 2013-03, Vol.185 (5), p.421-421

Canavan, James B.

2013

Volltextzugriff (PDF)

Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension

Journal of Crohn's and colitis, 2024-02, Vol.18 (2), p.264-274

2024

Volltextzugriff (PDF)

Determining the economic cost of ICU treatment: a prospective “micro-costing” study

Intensive care medicine, 2009-12, Vol.35 (12), p.2135-2140

2009

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(241)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Life Sciences & Biomedicine
(118)
Humans
(103)
Male
(61)
Female
(59)
Adult
(53)
Biological And Medical Sciences
(43)
Middle Aged
(42)
Medical Sciences
(34)
Aged
(23)
Physical Sciences
(19)
Physics
(17)
Adolescent
(16)
Gastroenterology & Hepatology
(16)
Hiv
(16)
Fundamental And Applied Biological Sciences. Psychology
(15)
Human Immunodeficiency Virus
(14)
Oncology
(14)
Animals
(12)
Endocrinology & Metabolism
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Sustainable tourism: development, decline and de-growth. Management issues from the Isle of Man

The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor+ Innate Lymphoid Cells

Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis

Improved Insulin Sensitivity despite Increased Visceral Adiposity in Mice Deficient for the Immune Cell Transcription Factor T-bet

Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls: Implications for Cell Therapy in Transplantation

Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions

EVALUATION OF OMALIZUMAB IN THE TREATMENT OF ALLERGIC RHINITIS

Real world incidence, severity and timing of adverse events (AEs) among patients with metastatic non-small cell lung cancer (NSCLC) receiving second-line (2L) immuno-oncology (IO) therapy vs chemotherapy (C)

Flexible Fiberoptic Bronchoscopy Service; An aid to patient management

Molecular Comparison of Adult and Pediatric Ulcerative Colitis Indicates Broad Similarity of Molecular Pathways in Disease Tissue

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease

Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis

S825 Efficacy of Ozanimod in Vedolizumab-Exposed Patients With Ulcerative Colitis: A Phase 3 True North Post Hoc Analysis

S731 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Baseline Endoscopic Disease Distribution: A Post Hoc Analysis of the Phase 3 True North Study

Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials

Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation

Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials

S723 Duration of Response to Ozanimod After Treatment Withdrawal: Results From the Phase 3 True North Study

S757 Efficacy and Safety of 2 Years of Continuous Ozanimod Treatment: Interim Analysis of the True North Open-Label Extension Study

S732 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Moderate orSevere Endoscopic Disease Activity at Baseline: A Post Hoc Analysis of the Phase 3 True North Study

CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL‐17 in a STAT3‐dependent manner

Prevalence and Severity of Diverticular Disease in the Post-Lung Transplant Population – A Single Center’s Experience

Statistics 101

Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension

Determining the economic cost of ICU treatment: a prospective “micro-costing” study

Suchergebnisse filtern